Top

Published in:

20-09-2022 | Myocardial Infarction

Protective Effect of Ginsenosides Rg1 on Ischemic Injury of Cardiomyocytes After Acute Myocardial Infarction

Authors: Chuang Yang, Guopan Jiang, Yue Xing

Published in: Cardiovascular Toxicology | Issue 10-11/2022

Abstract

Acute myocardial infarction (AMI) leads to anoxia and ischemia of cardiomyocytes, followed by apoptosis. This study investigated the protective effect of ginsenoside Rg1 (Rg1) on myocardial ischemia injury in rats with AMI. Rats were randomly divided into five groups: group A (blank control group), group B (hypoxia/reoxygenation group), group C (hypoxia/reoxygenation + 10 mg/L Rg1), group D (hypoxia/reoxygenation + 20 mg/L Rg1) and group E (hypoxia/reoxygenation + 40 mg/L Rg1). The survival rate, apoptosis rate, expression of cyclin-dependent kinase 4 (CDK4), fibroblast growth factor 9 (FGF9), superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px), microvessel density and myocardial infarction area of rats in each group were compared. The expressions of CDK4 and FGF9, the contents of SOD and GSH-Px in groups C, D and E injected with Rg1 were significantly promoted compared to group B without Rg1 injection (P < 0.05). The survival rate of myocardial cells was significantly increased while the apoptosis rate was significantly decreased in group C, D, E compared to group B (P < 0.05). On the 3rd, 7th and 10th day following Rg1 treatment, the infarct area of E group was significantly decreased in three groups C, D, E, and the microvessel density of infarct area was significantly increased compared with group B (P < 0.05). So, Rg1 can improve the survival rate of myocardial cells, reduce the apoptosis rate and the area of myocardial infarction, and increase the microvessel density of infarct area, thus playing a protective role in ischemic myocardial cells of AMI rats.

Amini, N., Sarkaki, A., Dianat, M., Mard, S. A., Ahangarpour, A., & Badavi, M. (2019). Protective effects of naringin and trimetazidine on remote effect of acute renal injury on oxidative stress and myocardial injury through Nrf-2 regulation. Pharmacological Reports, 71(6), 1059–1066. https://doi.org/10.1016/j.pharep.2019.06.007CrossRefPubMed

Yeh, J. S., Hsu, C. Y., Huang, C. Y., Chen, W. T., Hsieh, Y. C., & Chien, L. N. (2021). The effect of de-escalation of P2Y12 receptor inhibitor therapy after acute myocardial infarction in patients undergoing percutaneous coronary intervention: A nationwide cohort study. PLoS ONE, 16(1), e0246029. https://doi.org/10.1371/journal.pone.0246029CrossRefPubMedPubMedCentral

Zhang, Q., Xiao, X. H., Li, M., et al. (2014). Chromium-containing traditional Chinese medicine, Tianmai Xiaoke Tablet improves blood glucose through activating insulin-signaling pathway and inhibiting PTP1B and PCK2 in diabetic rats. Journal of Integrative Medicine, 12, 162–170. https://doi.org/10.1016/S2095-4964(14)60020-0CrossRefPubMed

Liu, Q., Zhang, F. G., Zhang, W. S., Pan, A., Yang, Y. L., Liu, J. F., Li, P., Liu, B. L., & Qi, L. W. (2017). Ginsenoside Rg1 inhibits glucagon-induced hepatic gluconeogenesis through akt-foxo1 interaction. Theranostics, 7(16), 4001–4012. https://doi.org/10.7150/thno.18788CrossRefPubMedPubMedCentral

Yao, Z., Zhang, L., & Ji, G. (2014). Efficacy of polyphenolic ingredients of Chinese herbs in treating dyslipidemia of metabolic syndromes. Journal of Integrative Medicine, 12, 135–146. https://doi.org/10.1016/S2095-4964(14)60023-6CrossRefPubMed

Sayour, A. A., Korkmaz-Icöz, S., Loganathan, S., Ruppert, M., Sayour, V. N., Oláh, A., Benke, K., Brune, M., Benkő, R., Horváth, E. M., Karck, M., Merkely, B., Radovits, T., & Szabó, G. (2019). Acute canagliflozin treatment protects against in vivo myocardial ischemia–reperfusion injury in non-diabetic male rats and enhances endothelium-dependent vasorelaxation. Journal of translational medicine., 17(1), 127. https://doi.org/10.1186/s12967-019-1881-8CrossRefPubMedPubMedCentral

Qi, L. W., Wang, C. Z., & Yuan, C. S. (2011). Isolation and analysis of ginseng: Advances and challenges. Natural Products Reports, 28, 467–495. https://doi.org/10.1039/c0np00057dCrossRef

Shen, C. Y., Jiang, J. G., Yang, L., Wang, D. W., & Zhu, W. (2017). Anti-ageing active ingredients from herbs and nutraceuticals used in traditional Chinese medicine: Pharmacological mechanisms and implications for drug discovery. British Journal of Pharmacology, 174(11), 1395–1425. https://doi.org/10.1111/bph.13631CrossRefPubMed

Chu, S. F., & Zhang, J. T. (2009). New achievements in ginseng research and its future prospects. Chinese Journal of Integrative Medicine, 15(6), 403–408. https://doi.org/10.1007/s11655-009-0403-6CrossRefPubMed

10.

Gao, Y., Li, J., Wang, J., Li, X., Li, J., Chu, S., Li, L., Chen, N., & Zhang, L. (2020). Ginsenoside Rg1 prevent and treat inflammatory diseases: A review. International Immunopharmacology, 87, 106805. https://doi.org/10.1016/j.intimp.2020.106805CrossRefPubMed

11.

Xie, W., Zhou, P., Sun, Y., Meng, X., Dai, Z., Sun, G., & Sun, X. (2018). Protective effects and target network analysis of ginsenoside Rg1 in cerebral ischemia and reperfusion injury: A comprehensive overview of experimental studies. Cells, 7(12), 270. https://doi.org/10.3390/cells7120270CrossRefPubMedCentral

12.

Fan, W., Huang, Y., Zheng, H., Li, S., Li, Z., Yuan, L., Cheng, X., He, C., & Sun, J. (2020). Ginsenosides for the treatment of metabolic syndrome and cardiovascular diseases: Pharmacology and mechanisms. Biomedicine & Pharmacotherapy, 132, 110915. https://doi.org/10.1016/j.biopha.2020.110915CrossRef

13.

Sun, X., Li, C., & Lu, J. (2019). Protective effect of ginsenoside Rd against isoproterenol induced myocardial infarction in Wistar rats. Tropical Journal of Pharmaceutical Research, 18(1), 93.CrossRef

14.

Antiochos, P., & Yin, G. (2021). Effects of Omega-3 fatty acids on ventricular remodeling and systemic inflammation after acute myocardial infarction. Journal of the American College of Cardiology, 77(7), 1026. https://doi.org/10.1016/j.jacc.2020.11.071CrossRefPubMed

15.

Bhatti, M., Ayton, S., Michail, O., Gollop, N. D., Ryding, A., Rushworth, S., Bowles, K., Geisler, T., & Flather, M. (2019). Effect of Bruton’s tyrosine kinase inhibitors on platelet aggregation in patients with acute myocardial infarction. Thrombosis Research, 179, 64–68. https://doi.org/10.1016/j.thromres.2019.04.024CrossRefPubMed

16.

Salyamova, L., Kvasova, O., Tomashevskaya, Y., Burko, N., & Oleynikov, V. (2020). Nephroprotective effect of atorvastatin in patients with acute myocardial infarction. Atherosclerosis, 315, 53–54.CrossRef

17.

Akinrinde, A. S., Oduwole, O., Akinrinmade, F. J., & Bolaji-Alabi, F. B. (2020). Nephroprotective effect of methanol extract of Moringa oleifera leaves on acute kidney injury induced by ischemia-reperfusion in rats. African Health Sciences., 20(3), 1382–1396. https://doi.org/10.4314/ahs.v20i3.44CrossRefPubMedPubMedCentral

18.

Santos, R. B., Silveira, I., Trêpa, M., Brochado, B., Magalhães, R., Rodrigues, P., Sousa, M. J., Luz, A., Silveira, J., Albuquerque, A., Torres, S., Leite-Moreira, A. F., & Carvalho, H. (2019). The impact of preinfarct angina on the incidence of acute kidney injury in patients with myocardial infarction: Interaction with pre-existent chronic kidney disease. Coronary Artery Disease, 30(7), 488–493. https://doi.org/10.1097/MCA.0000000000000710CrossRefPubMed

19.

Kazzi, M. E., Rayner, B. S., Chami, B., Dennis, J. M., Thomas, S. R., & Witting, P. K. (2020). Neutrophil-mediated cardiac damage after acute myocardial infarction: significance of defining a new target cell type for developing cardioprotective drugs. Antioxidants & Redox Signaling, 33(10), 689–712. https://doi.org/10.1089/ars.2019.7928CrossRef

20.

Hosseini, M. S., Fakhri, M. A., Hashemzadeh, S., & Farhoudi, M. (2020). Effect of erythropoietin on inflammatory response and ischemic brain damage after carotid artery clamp in rat. Journal of Cerebral Blood Flow and Metabolism, 39(1), 363–364.

21.

Shen, L., & Zhang, J. (2007). NMDA receptor and iNOS are involved in the effects of ginsenoside Rg1 on hippocampal neurogenesis in ischemic gerbils. Neurological Research, 29(3), 270–273. https://doi.org/10.1179/016164107X159144CrossRefPubMed

22.

Romero-Parra, N., Rael, B., Alfaro-Magallanes, V. M., Janse de Jonge, X., Cupeiro, R., Peinado, A. B., IronFEMME Study Group. (2021). The effect of the oral contraceptive cycle phase on exercise-induced muscle damage after eccentric exercise in resistance-trained women. The Journal of Strength & Conditioning Research., 35(2), 353–359. https://doi.org/10.1519/JSC.0000000000003897CrossRef

23.

Pastormerlo, L. E., Burchielli, S., Ciardetti, M., Aquaro, G. D., Grigoratos, C., Castiglione, V., Pucci, A., Franzini, M., Giorgetti, A., Marzullo, P., Benelli, E., Masotti, S., Musetti, V., Bernini, F., Berti, S., Passino, C., & Emdin, M. (2021). Myocardial salvage is increased after sympathetic renal denervation in a pig model of acute infarction. Clinical Research in Cardiology, 110(5), 711–724. https://doi.org/10.1007/s00392-020-01685-yCrossRefPubMed

24.

Ousefi, K., Fathiazad, F., Soraya, H., Rameshrad, M., Maleki-Dizaji, N., & Garjani, A. (2014). Marrubium vulgare L. methanolic extract inhibits inflammatory response and prevents cardiomyocyte fibrosis in isoproterenol-induced acute myocardial infarction in rats. BioImpacts: BI, 4(1), 21–27. https://doi.org/10.5681/bi.2014.001CrossRef

25.

Komarova, I. S., Karova, L. B., Andreeva, N. V., Cherkasova, N. A., & Zhelnov, V. V. (2019). Effect of myocardial reperfusion on ischemic mitral regurgitation in patients with acute myocardial infarction. Kardiologiia, 59(5), 18–25. https://doi.org/10.18087/cardio.2019.5.2607CrossRefPubMed

26.

Volney, C., Collins, A., & Adams, S. (2019). Ticagrelor versus clopidogrel in the management of acute myocardial infarction. Journal of community hospital internal medicine perspectives, 9(4), 314–318. https://doi.org/10.1080/20009666.2019.1644915CrossRefPubMedPubMedCentral

27.

Qin, L., Fan, S., Jia, R., & Liu, Y. (2018). Ginsenoside Rg1 protects cardiomyocytes from hypoxia-induced injury through the PI3K/AKT/mTOR pathway. Die Pharmazie-An International Journal of Pharmaceutical Sciences, 73(6), 349–355. https://doi.org/10.1691/ph.2018.8329CrossRef

Title: Protective Effect of Ginsenosides Rg1 on Ischemic Injury of Cardiomyocytes After Acute Myocardial Infarction
Authors: Chuang Yang
Guopan Jiang
Yue Xing
Publication date: 20-09-2022
Publisher: Springer US
Keyword: Myocardial Infarction
Published in: Cardiovascular Toxicology / Issue 10-11/2022
Print ISSN: 1530-7905
Electronic ISSN: 1559-0259
DOI: https://doi.org/10.1007/s12012-022-09767-1

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Protective Effect of Ginsenosides Rg1 on Ischemic Injury of Cardiomyocytes After Acute Myocardial Infarction

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 10-11/2022

Alpha-Lipoic Acid Protects Against Doxorubicin-Induced Cardiotoxicity by Regulating Pyruvate Dehydrogenase Kinase 4

Genistein Alleviates Oxidative Stress and Inflammation in the Hypothalamic Paraventricular Nucleus by Activating the Sirt1/Nrf2 Pathway in High Salt-Induced Hypertension

Dapagliflozin Guards Against Cadmium-Induced Cardiotoxicity via Modulation of IL6/STAT3 and TLR2/TNFα Signaling Pathways

PD-1 Inhibitor-Induced Thyrotoxicosis Associated with Coronary Artery Spasm and Ventricular Tachycardia

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page